Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

NCT05677971 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha1-Antitrypsin Deficiency

Interventions

DRUG: Fazirsiran Injection
OTHER: Placebo

Sponsor

Takeda

Collaborators

[object Object]